Recombinant human thyrotropin and thyroid cancer management

被引:32
作者
Robbins, RJ
Robbins, AK
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Div Gen Med, Endocrine Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Med Lib, Nathan Cummings Ctr, New York, NY 10021 USA
关键词
D O I
10.1210/jc.2002-021979
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1933 / 1938
页数:6
相关论文
共 49 条
[31]   Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects [J].
Ramirez, L ;
Braverman, LE ;
White, B ;
Emerson, CH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) :2836-2839
[32]   Pharmacology of bovine and human thyrotropin: An historical perspective [J].
Robbins, J .
THYROID, 1999, 9 (05) :451-453
[33]  
Robbins R J, 2000, Endocr Pract, V6, P460
[34]   Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? [J].
Robbins, RJ ;
Chon, JT ;
Fleisher, M ;
Larson, SM ;
Tuttle, RM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (07) :3242-3247
[35]  
Robbins RJ, 2002, J NUCL MED, V43, P1482
[36]   Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin [J].
Robbins, RJ ;
Tuttle, RM ;
Sonenberg, M ;
Shaha, A ;
Sharaf, R ;
Robbins, H ;
Fleisher, M ;
Larson, SM .
THYROID, 2001, 11 (09) :865-869
[37]   Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma [J].
Robbins, RJ ;
Tuttle, RM ;
Sharaf, RN ;
Larson, SM ;
Robbins, HK ;
Ghossein, RA ;
Smith, A ;
Drucker, WD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :619-625
[38]   Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii [J].
Rotman-Pikielny, P ;
Reynolds, JC ;
Barker, WC ;
Yen, PM ;
Skarulis, MC ;
Sarlis, NJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :237-244
[39]   Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine I-131 and recombinant human thyroid stimulating hormone [J].
Rudavsky, AZ ;
Freeman, LM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :11-14
[40]   Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer [J].
Santini, F ;
Bottici, V ;
Elisei, R ;
Montanelli, L ;
Mazzeo, S ;
Basolo, F ;
Pinchera, A ;
Pacini, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) :4160-4165